The programme is intended to be a book-ended meeting where the keynotes and first session are designed to give an overview of what we know about the molecular and infection biology of Shigella, the burden and distribution of disease across settings, and the diversity of the pathogen; effectively outlining the challenge and the state of play for the community. The middle sessions of infection models, molecular mechanisms, and pathology and immunology will then give an overview of the knowledge and tools we have available to study and emphasize key knowledge gaps in our understanding of Shigella, while highlighting fundamental discoveries that improve our understanding of microbiology and cellular biology. And finally, the closing session on vaccines and therapeutics and policy panel discussion will set the direction for future work and highlight the remaining research challenges for the development of tools to control the disease. This interchange between basic and applied research is also structured to ensure that participants are incentivized to attend the entire programme.

April, 20^th

April, 21^st

April, 22^nd

April, 23^rd

April, 24^th